Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mapi Pharma Ltd.

Clinical trials sponsored by Mapi Pharma Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New monthly shot could simplify mental health treatment Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Completed 1 Terminated 1

Monthly MS injection aims to halt disability progression

Disease control Stopped early

This study tested a long-acting form of glatiramer acetate (GA Depot) given as a monthly shot to people with primary progressive multiple sclerosis (PPMS). The goal was to see if it could safely slow down worsening disability. The trial was stopped early, but it involved 30 adult…

Phase 2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC